This effect is thought to be beneficial since experimental evidence suggests that persistent activation of TLR4-induced inflammatory signalling during chronic inflammation can contribute to carcinogenesis [43], and cancer cell survival, proliferation, migration, and invasion are induced by triggering of the TLR4–NF-κB signalling pathway under inflammatory conditions [44,45]. Here, NFKB1 is linked to cancer.